Fortrea Holdings (FTRE) Enterprise Value (2022 - 2026)
Fortrea Holdings (FTRE) posted Enterprise Value of -$147.5 million for Q1 2026, up 15.52% on a QoQ basis from -$174.6 million in Q4 2025, and down 45.18% year-over-year from -$269.0 million in Q1 2025.
Fortrea Holdings (FTRE) Enterprise Value (2022 - 2026) Analysis & Trends
Fortrea Holdings' Enterprise Value history runs 5 years deep, the most recent figure standing at -$147.5 million for Q1 2026.
- Quarterly Enterprise Value fell 45.18% year-over-year to -$147.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$147.5 million (down 45.18% YoY) and the FY2025 annual result came in at -$174.6 million, down 47.34% from the prior year.
- Enterprise Value was -$147.5 million for Q1 2026 at Fortrea Holdings, up from -$174.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$81.2 million in Q2 2025 and bottomed at -$174.6 million in Q4 2025.
- A 5-year average of -$117.0 million and a median of -$112.0 million in 2022 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 35.66% in 2025, while the deepest fall reached 47.34% in 2025.
- Fortrea Holdings' Enterprise Value stood at -$112.0 million in 2022, then gained by 3.04% to -$108.6 million in 2023, then fell by 9.12% to -$118.5 million in 2024, then tumbled by 47.34% to -$174.6 million in 2025, then rose by 15.52% to -$147.5 million in 2026.
- Business Quant data shows FTRE's Enterprise Value at -$147.5 million in Q1 2026, -$174.6 million in Q4 2025, and -$131.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | -147.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -147.50 Mn |
| Dec 31, 2025 | -174.60 Mn |
| Sep 30, 2025 | -131.30 Mn |
| Jun 30, 2025 | -81.20 Mn |
| Mar 31, 2025 | -101.60 Mn |
| Dec 31, 2024 | -118.50 Mn |
| Sep 30, 2024 | -105.30 Mn |
| Jun 30, 2024 | -126.20 Mn |
| Mar 31, 2024 | -92.80 Mn |
| Dec 31, 2023 | -108.60 Mn |
| Sep 30, 2023 | -107.50 Mn |
| Jun 30, 2023 | -114.30 Mn |
| Dec 31, 2022 | -112.00 Mn |